期刊文献+

氟喹诺酮类药物与甲氧苄啶联合抗菌作用的实验研究 被引量:7

THE EXPERIMENTAL RESEARCH ON CONSOLIDATED ANTI-BACTERIAL ACTION OF FLUOROQUINOLONES MEDICINES AND TRIMETHOPRIN.
下载PDF
导出
摘要 目的:探讨TMP对氟喹诺酮类药物的增效作用,以及与氟喹诺酮类药物的最佳配伍比例.方法:将菌液制成0.5麦氏比浊标准,采用肉汤稀释法测定细菌对TMP和氟喹诺酮类药物的MIC;按棋盘法设计测定7种氟喹诺酮类药物和TMP联合试验时FIC,判断各药与TMP联合作用效应.结果:选择的7种氟喹诺酮类药物与TMP配伍使用均产生协同作用或相加作用,使各氟喹诺酮类药物抗菌作用增强1~4倍,不同的氟喹诺酮类药物与TMP配伍的最佳比例因药物和受试菌的种类不同而异.结论:氟喹诺酮类药物与TMP联合应用能起协同作用,但TMP对不同的氟喹诺酮类药物的增效作用不完全相同,二者配伍也不一.临床上在配伍使用前应作联合药敏试验,以选择最佳配伍比例. Objective: To probe the effect- enhancement of TMP to fluoroquinolones medicines and the best blend proportion of TMP and fluoroquinolones medicines. Methods: Bacterial fluid of 0.5 McFarland standard and broth dilution method was used to test its MIC to TMP and fluoroqulnolones medicines; checkerboard method was also used to determine FIC of seven fluoroquinolones medicines and TMP during consolidated experiments, thus to determine the respective effect. Results: When seven kinds of fluoroquinolones medicines were respectively blended and used with TMP, synergism of addition occured and anti - bacterial action of fluoroquinolones increased by 1 - 4 times. The best blend proportion of fluoroqluinolones medicines and TMP was different because of the different kinds of fluoroquinolones medicines and tested bacteria. Conclusion: The consolidated usage of fluoroquinolones medicines and TMP can cause synergism, but the effect - enhancement of TMP to different fluoroquinolones medicines is not absolutely the same and their blend proportion is also different. In clinical practice consolidated test should be made before blend usage in order to choose the best proportion.
出处 《现代预防医学》 CAS 北大核心 2005年第12期1607-1609,共3页 Modern Preventive Medicine
基金 台州学院课题(编号:04ND542)
关键词 甲氧苄啶 氟喹诺酮类药物 G^+菌 G^-菌 联合抗菌作用 Trimethoprin Fluoroquinolones medicines G^+ bacterium G^- bacterium consolidated anti - bacterial action
  • 相关文献

参考文献4

  • 1徐叔云 卞如濂 陈修.药理实验方法学[M].北京:人民卫生出版社,2003.1532-1533.
  • 2张伦.甲氧苄啶的应用、生产和市场状况[J].中国药房,2001,12(3):142-144. 被引量:8
  • 3Fung-Tomc J,Minassian B.In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone,gatifloxacin[J].J Antimicrob Chemother,2000,45 (4):437-446.
  • 4Fung-Tomc J,Minassian B,DenBleyker K,et al.Test factor effects on gatifloxacin Antibacterial inhibitory and bactericidal activities[A].Program and abstracts of the thirty-eighth interscience conference on antimicrobial agents and chemotherapy (San Diego,California,1998)[C].Washington DC:American Society Microbiology,1998,Abstract E179,221-226.

二级参考文献3

  • 1陈新谦,金有豫,主编新编药物学[M].第14版.北京:人民卫生出版社,1998:44~95
  • 2刘俊生.印度原料药工业隐忧仍在[J].医药经济信息,2000,18:22-22.
  • 3程书权,王志建.复方新诺明临床拓宽应用研究[J].国外医药(合成药.生化药.制剂分册),1997,18(1):25-28. 被引量:2

共引文献154

同被引文献60

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部